BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21800533)

  • 1. [Effects of posttranslational modification on the activity of cytochrome P450: current progress].
    Li YH; Bi HC; Huang M
    Yao Xue Xue Bao; 2011 May; 46(5):487-92. PubMed ID: 21800533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cytochrome P450 by posttranslational modification.
    Aguiar M; Masse R; Gibbs BF
    Drug Metab Rev; 2005; 37(2):379-404. PubMed ID: 15931769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the water channel aquaporin-2 by posttranslational modification.
    Moeller HB; Olesen ET; Fenton RA
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1062-73. PubMed ID: 21307124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative and other posttranslational modifications in extracellular vesicle biology.
    Szabó-Taylor K; Ryan B; Osteikoetxea X; Szabó TG; Sódar B; Holub M; Németh A; Pálóczi K; Pállinger É; Winyard P; Buzás EI
    Semin Cell Dev Biol; 2015 Apr; 40():8-16. PubMed ID: 25721811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme.
    Oesch-Bartlomowicz B; Oesch F
    Biochem Biophys Res Commun; 2005 Dec; 338(1):446-9. PubMed ID: 16137648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of tissue factor procoagulant activity by post-translational modifications.
    Egorina EM; Sovershaev MA; Osterud B
    Thromb Res; 2008; 122(6):831-7. PubMed ID: 18191444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of protein posttranslational modifications using DIGE-based proteomics.
    DeKroon RM; Robinette JB; Osorio C; Jeong JS; Hamlett E; Mocanu M; Alzate O
    Methods Mol Biol; 2012; 854():129-43. PubMed ID: 22311757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of nitric oxide with cytochrome P450 BM3.
    Quaroni LG; Seward HE; McLean KJ; Girvan HM; Ost TW; Noble MA; Kelly SM; Price NC; Cheesman MR; Smith WE; Munro AW
    Biochemistry; 2004 Dec; 43(51):16416-31. PubMed ID: 15610036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic disposition and effects of nitric oxide donors: rapid and concentration-dependent reduction in the cytochrome P450-mediated drug metabolism in isolated perfused rat livers.
    Vuppugalla R; Mehvar R
    J Pharmacol Exp Ther; 2004 Aug; 310(2):718-27. PubMed ID: 15051803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity.
    Schulze PC; Liu H; Choe E; Yoshioka J; Shalev A; Bloch KD; Lee RT
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2666-72. PubMed ID: 17023680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of cytochrome P450 enzymes in human nasopharyngeal carcinoma and non-cancerous nasopharynx tissue].
    Jiang JH; Jia WH; Qin HD; Liang H; Pan ZG; Zeng YX
    Ai Zheng; 2004 Jun; 23(6):672-7. PubMed ID: 15191668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerous posttranslational modifications provide opportunities for the intricate regulation of metabolic enzymes at multiple levels.
    Huber SC; Hardin SC
    Curr Opin Plant Biol; 2004 Jun; 7(3):318-22. PubMed ID: 15134753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.
    Dani M; Boisvert C; Michaud J; Naud J; Lefrançois S; Leblond FA; Pichette V
    Drug Metab Dispos; 2010 Mar; 38(3):357-60. PubMed ID: 20007296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational elevation of cytochrome P450 3A levels and activity by dimethyl sulfoxide.
    Zangar RC; Novak RF
    Arch Biochem Biophys; 1998 May; 353(1):1-9. PubMed ID: 9578594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice.
    Armstrong SG; Renton KW
    Mol Pharmacol; 1993 Apr; 43(4):542-7. PubMed ID: 8379989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation.
    Lane P; Hao G; Gross SS
    Sci STKE; 2001 Jun; 2001(86):re1. PubMed ID: 11752656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences.
    Martínez-Ruiz A; Lamas S
    Cardiovasc Res; 2007 Jul; 75(2):220-8. PubMed ID: 17451659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination, phosphorylation, and acetylation--triple threat in muscle wasting.
    Hasselgren PO
    J Cell Physiol; 2007 Dec; 213(3):679-89. PubMed ID: 17657723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of water extract from traditional Chinese medicines Rehmannia glutinosa, Scrophularia ningpoensis, Asparagus cochinchinensis and Ophiopogon japonicas on contents of CYP450 and activities of CYP3A, CYP2E1 and CYP1A2 in rat].
    Wu B; Liu P; Gao Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2710-4. PubMed ID: 22242435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways.
    Wang H; Lin L; Jiang J; Wang Y; Lu ZY; Bradbury JA; Lih FB; Wang DW; Zeldin DC
    J Pharmacol Exp Ther; 2003 Nov; 307(2):753-64. PubMed ID: 12975498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.